Soft Tissue Repair Market Analysis

Soft Tissue Repair Market Overview

The Soft Tissue Repair Marke is anticipated to reach USD 13.43 billion by 2030 at CAGR 4.20% during the forecast period 2022-2030. Soft tissue is a type of injury that involves damage to the muscles, ligaments, and tendons, leading to pain and inflammation. The process is characterized by replacing the damaged tissue with a healthy one. The recent treatment procedures are dependent on surgical procedures, but the process does not consist of a success rate. Therefore, people are finding superior, technologically advanced alternatives with a rapid healing process. The growing sports-related injuries are one of the major factors for the market growth. Including that, technological advancement in every sector will also improve the current market size. Several more growth factors are present for the market, which pushes the market. Increasing awareness about orthopedic disorders and other conditions will positively impact the market. Increasing healthcare expenditure by the government is one factor that drives the market. However, certain restraints like the high price of advanced equipment and the lack of physicians in emerging markets will hamper the market. The market has to overcome all the challenges to reach its peak globally.

Soft Tissue Repair Market Segment Insights

The soft tissue repair market is segmented based on product, application, end user, and region.

Soft Tissue Repair Product Insights

the market is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others. The fixation products segment is further classified as a suture, suture anchors, and interference screw. The tissue patch/match segment is further classified as biological, and synthetic. The biological segment includes allograft and xenograft.

Soft Tissue Repair Application Insights

the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.

Soft Tissue Repair End-User Insights

the market is segmented into hospitals, clinics, research & academic institutes, and others.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European soft tissue repair market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The soft tissue repair market in the Middle East & Africa has been segmented into the Middle East and Africa.

Soft Tissue Repair Regional Market Summary

Global Soft Tissue Repair Market Share (%), by Region, 2017

Sources: MRFR Analysis

The Americas dominated the global market for soft tissue repair owing to the increasing healthcare expenditure presence of major market players and rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058.

In 2017, it was estimated that Europe stood second in the soft tissue repair market. Robust research and development (R&D) sector along with the availability of funding opportunities in research and innovation will support the market growth.

Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases in India, Japan, and Australia. For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, around 12.4% of the population in the region was 60 years or older and is projected to reach to more than 1.3 billion by 2050.

On the other hand, the Middle East and Africa held the least share in the soft tissue repair market due to the low economic development, especially within the African region.

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

• Primary Research

Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the soft tissue repair market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.

Recent Development

In May 2022

3D models could lead to a deeper understanding of fracture nonunions and progress in healing.

In April 2022

the Bioadhesives are currently a research focus in the biomedical industry. The requirement for these adhesives and drug delivery systems has been partly facilitated by an aging population and increasing healthcare costs.

There is only one FDA-cleared, long-duration, home-use ultrasound device called ZetrOZ's sam®, which use to increase local circulation and heal pain and is designed for easy daily use as necessary. More than 30 peer-reviewed studies have found it an innovative and effective treatment to promote injury healing, relieve pain, restore function, and return patients to work, sports, and other daily activities.

Intended Audience

• Medical Devices Companies


• Government and Private Laboratories


• Research and Development (R&D) Companies


• Research Laboratories


• Market Research and Consulting Service Providers

Soft Tissue Repair Market Segmentation

Soft Tissue Repair Market Product Outlook

• Fixation Products




• Suture


• Suture Anchors


• Interference Screw




• Tissue Patch/Match




• Biological




• Allograft


• Xenograft




• Synthetic




• Laparoscopic Instrument


• Others

Soft Tissue Repair Market Application Outlook

• 
  Orthopedic Surgery


• Skin Repair


• Hernia Repair


• Vaginal Sling Repair


• Dental Reconstruction


• 
  Cardiovascular Surgery


• Breast Reconstruction


• Others

Soft Tissue Repair Market End User Outlook

• Hospitals


• Clinics


• Research & Academic Institutes


• Others

Soft Tissue Repair Market Key Players

• Stryker Corporation


• R. Bard, Inc.


• Arthrex, Inc.


• Integra LifeScience Corporation


• Depuy Synthes


• Smith & Nephew PLC


• Allergan Plc.


• Athersys, Inc.


• CryoLife, Inc.


• Medtronic Plc.


• Organogenesis Inc.


• Zimmer Biomet Holdings, Inc.


• Lifenet Health, Inc.


• American Medical Systems Inc.


• S. Stem Cell, Inc.


• 
  Wright Medical Group, Inc.


• Isto Biologics